The role of vaccines in reducing antimicrobial resistance: A review of potential impact of vaccines on AMR and insights across 16 vaccines and pathogens
Mateusz Hasso-Agopsowicz(World Health Organization), William P. Hausdorff(Program for Appropriate Technology in Health), Kirsty Le Doaré(St George's, University of London), Birgitte Giersing(World Health Organization), Sami L. Gottlieb(World Health Organization), Adwoa Bentsi-Enchill(World Health Organization), Erin Sparrow(Unknown), Hatim Sati(World Health Organization), Alexandra Meagan Cameron(World Health Organization), Mary J. Hamel(World Health Organization), Padmini Srikantiah(Gates Foundation)
Cited by 40
Related Papers
Estimates of the global burden of cervical cancer associated with HIV
|The Lancet Global Health|2020|912
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses
|Clinical Infectious Diseases|2017|453
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451